MSC-based therapy in female pelvic floor disorders

Area of Science:

• Regenerative Medicine
• Cell Biology
• Gynecology

Background:

• Pelvic floor disorders (PFDs) are common in women, significantly impacting quality of life.
• Current treatments for PFDs have limitations, including high recurrence rates and surgical complications.
• There is an urgent need for effective therapies to restore pelvic floor function.

Purpose of the Study:

• To review mesenchymal stem cell (MSC) sources for PFD treatment.
• To discuss the therapeutic mechanisms of MSCs in PFDs.
• To summarize preclinical and clinical trials of MSC-based therapy for PFDs.

Main Methods:

• Literature review of MSC sources and mechanisms.
• Analysis of preclinical and clinical trial data for MSC-based PFD therapies.
• Synthesis of current evidence on MSC applications in PFDs.

Main Results:

• MSCs offer potential therapeutic effects for PFDs, including symptom relief and tissue repair.
• MSC therapy can improve the integration and performance of implanted surgical meshes.
• Preclinical and clinical studies indicate promising outcomes for MSC-based PFD treatments.

Conclusions:

• MSC-based therapy presents a promising novel approach for treating PFDs.
• Further investigation into the safety and efficacy of MSCs for PFDs is crucial.
• Addressing outstanding questions is necessary before widespread clinical adoption of MSC therapies for PFDs.